Shares of Titan Pharmaceuticals Inc. (OTC: TTNP), a biopharmaceutical company engaged in the development of proprietary therapeutics primarily for the treatment of central nervous system disorders in the U.S., are climbing in trading today. At last check, TTNP shares were trading 5.71% higher at $1.85 on volume of 422,703. The stock hit an intra-day high [...]
Recent Comments